Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category

European Journal of Surgical Oncology

Volumn 33, Issue 1, 2007, Pages 16-22

  Gimbergues, P ^a   Dauplat, M M ^a   Cayre, A ^a   Durando, X ^a   Le Bouedec, G ^a   Finat Duclos, F ^a   Portefaix, G ^a   Kwiatkowski, F ^a   Dauplat, J ^a   Penault Llorca, F ^a   Tchirkov, A ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

Breast cancer; Metastasis; Real time RT PCR; Sentinel lymph node

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; MAMMAGLOBIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FOLLOW UP; GENE EXPRESSION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, NEOPLASM; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 33846375866     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.013     Document Type: Article

References (28)

1. Harris J.R., Lippman M.E., Morrow M., and Hellman S. Diseases of breast (1995), Lippicott-Raven, Philadelphia
2. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
3. Smith B.L. Approaches to breast-cancer staging. N Engl J Med 342 (2000) 580-581
4. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335 (1990) 1565-1568
5. Cote R.J., Peterson H.F., Chaiwun B., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900
6. Noguchi S., Aihara T., Nakamori S., et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction. Cancer 74 (1994) 1600-1995
7. Min C.J., Tafra L., and Verbanac K.M. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 58 (1998) 4581-4584
8. Mitas M., Mikhitarian K., Walters C., et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93 (2001) 162-171
9. Backus J., Laughlin T., Wang Y., et al. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7 (2005) 327-336
10. Bostick P.J., Huynh K.T., Sarantou T., et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 79 (1998) 645-651
11. Lockett M.A., Baron P.L., O'Brien P.H., et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg 187 (1998) 9-16
12. Manzotti M., Dell'Orto P., Maisonneuve P., Zurrida S., Mazzarol G., and Viale G. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 95 (2001) 307-312
13. Marchetti A., Buttitta F., Bertacca G., et al. M RNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol 195 (2001) 186-190
14. Sakaguchi M., Virmani A., Dudak M.W., et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol 10 (2003) 117-125
15. Nissan A., Jager D., Roystacher M., et al. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 94 (2006) 681-685
16. Gillanders W.E., Mikhitarian K., Hebert R., et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors prognosis. Ann Surg 239 (2004) 828-840
17. Mikhitarian K., Martin R.H., Mitas M., et al. et al Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery 138 (2005) 474-481
18. Hughes S.J., Xi L., Raja S., et al. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 243 (2006) 389-398
19. Dell'orto P., Olivia Biasi M., Del Curto B., Zurrida S., Galimberti V., and Viale G. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat 98 (2006) 185-190
20. Noguchi S., Aihara T., Motomura K., Inaji H., Imaoka S., and Koyama H. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse-transcriptase polymerase chain reaction. Cancer 78 (1996) 1235-1240
21. Masuda N., Tamaki Y., Sakita I., et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res 6 (2000) 4176-4185
22. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system breast cancer. J Clin Oncol 20 (2002) 3628-3636
23. Singletary S.E., Allred C., Ashley P., et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83 (2003) 803-819
24. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., Thürlimann B., Senn H.-J., and Panel Members. Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005. Ann Oncol 16 (2005) 1569-1583
25. Gerhard M., Juhl H., Kalthoff H., Scheirber H.W., Wagener C., and Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12 (1994) 725-729
26. Tchirkov A., Giollant M., Tavernier F., et al. Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukemia during interferon-a therapy. Br J Haematol 101 (1998) 552-557
27. Kwiatkowski F., Girard M., Hacene K., and Berlie J. Sem: a suitable statistical software adapted for research in oncology. Bull Cancer 87 (2000) 715-721
28. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., and Senn H.J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 3357-3365